Life Sciences

Serving life sciences companies for more than 25 years, Latham & Watkins represents leading and emerging companies in this broad and rapidly evolving industry.

Why Latham

Strategic Counsel

Life sciences companies worldwide rely on Latham’s unique combination of industry knowledge, legal acumen and strategic business expertise. Many of the firm’s lawyers hold advanced scientific degrees and have hands-on experience working in life sciences companies or within the government agencies that regulate the industry.

This deep understanding of the global life sciences industry allows Latham's lawyers to offer superior counsel to clients involved in transactions, investigations, litigation, intellectual property matters and regulatory challenges. They understand the economic, market, regulatory and political climates in which life sciences companies operate and integrate these factors when addressing clients’ legal and business needs.

Client-focused Representation

Latham represents public and private life sciences companies at all stages of development, from start-up and emerging growth to mature public companies, in the following industries:

  • Biofuels
  • Bioinformatics
  • Biotechnology
  • Cosmeceuticals 
  • Diagnostics
  • Drug delivery
  • eHealth
  • Genomics
  • Healthcare
  • Medical devices
  • Nanotechnology
  • Pharmaceuticals
  • Proteomics
  • Therapeutics

In addition, the firm’s lawyers play important roles in the industry, serving as primary outside counsel for the Advanced Medical Technology Association and as primary outside FDA counsel to the Medical Device Manufacturers Association. Latham also is a leader in key life sciences industry organizations including BIO, BayBio and BIOCOM.

Deep Industry Knowledge

Latham lawyers work closely with life sciences clients to address their legal needs and achieve their goals throughout the full life cycle of their companies. The firm also serves as company counsel in a range of areas, including:

Lawyers in this group assist clients in raising capital in:

The firm’s mergers and acquisitions work in the life sciences industry routinely includes:

Latham’s regulatory and enforcement work in the life sciences industry covers:

And its technology transactions have included:

  • Asset acquisitions
  • Commercial contracts and license agreements
  • Commercialization channel and sales agreements
  • Joint ventures
  • Outsourcing
  • R&D agreements
  • Strategic alliances
  • Supply and manufacturing agreements
  • University licensing

 Finally, Latham provides IP counseling and litigation services in areas such as:

Awards & Rankings

  • Intellectual Property Litigation Partner Named a Rising Star - May 16, 2018
  • Two Bay Area Partners Honored as Top Women Lawyers - May 15, 2018
  • Global Co-Chair Named Regulatory Trailblazer - May 06, 2018
  • Latham Honored as Capital Markets Practice Group of the Year - January 21, 2018
  • Silicon Valley Partner Honored Among “Women Leaders in Tech Law” - July 31, 2017
“A prestigious corporate workhorse, with additional expertise in IP litigation and regulatory matters,” and “a leading firm for handling IPOs.” The group also has “a market-leading national and international presence, drawing on impressive global resources.” 
Chambers USA 2014


Healthcare Financial Management Association Regional ConferenceFDLI Annual ConferenceWebcast: Recent Developments in Health Care Enforcement

Media Coverage

Top 40 Under 40: Jennifer KohZimmerBiomet Scores $13M In Fees In Howmedica IP FightTop Women Lawyers 2018: Judith Hasko


Intellectual Property Litigation Partner Named a Rising StarGlobal Co-Chair Named Regulatory TrailblazerLatham & Watkins Advises CVC on $703 Million Acquisition of Theramex

Thought Leadership

Pharma and Biotech: Key Trends and Legal RisksFDA Reauthorization Act Aims to Speed Product Reviews Through User Fee FundingTech, Pharma Divided Over Section 101 Challenges Post-Alice